Terms: = Bone cancer AND REL, I-Rel, 5966, ENSG00000162924, C-Rel AND Prognosis
3 results:
1. Allogeneic haematopoietic cell transplant in patients with relapsed/refractory anaplastic large cell lymphoma.
Furqan F; Ahn KW; Chen Y; Kaur M; Abutalib SA; Ahmed N; Ahmed S; Kharfan-Dabaja MA; Friedberg J; Gregory T; Hill L; Sterling C; Barta SK; Shadman M; Perales MA; Zain J; Herrera AF; Sauter C; Hamadani M
Br J Haematol; 2023 Jan; 200(1):54-63. PubMed ID: 36120837
[TBL] [Abstract] [Full Text] [Related]
2. Non-myeloablative allogeneic hematopoietic stem cell transplantation for adults with relapsed and refractory mantle cell lymphoma: a single-center analysis in the rituximab era.
Mussetti A; Devlin SM; Castro-Malaspina HR; Barker JN; Giralt SA; Zelenetz AD; Sauter CS; Perales MA
Bone Marrow Transplant; 2015 Oct; 50(10):1293-1298. PubMed ID: 26146802
[TBL] [Abstract] [Full Text] [Related]
3. Nuclear factor-κB activation in primary lymphoma of bone.
Koens L; Heyning FH; Szepesi A; Matolcsy A; Hogendoorn PC; Jansen PM
Virchows Arch; 2013 Mar; 462(3):349-54. PubMed ID: 23328932
[TBL] [Abstract] [Full Text] [Related]
